Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXA8CU
|
||||
| Drug Name |
N*6*-Imidazol-1-yl-N*4*-(1H-indol-5-yl)-N*6*-(3-phenyl-propyl)-thieno[3,2-d]pyrimidine-4,6-diamine
|
||||
| Synonyms |
CHEMBL312818
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H23N7S
|
||||
| Canonical SMILES |
C(CN(c1cc2ncnc(Nc3ccc4[nH]ccc4c3)c2s1)n5ccnc5)Cc6ccccc6
|
||||
| InChI |
InChI=1S/C26H23N7S/c1-2-5-19(6-3-1)7-4-13-33(32-14-12-27-18-32)24-16-23-25(34-24)26(30-17-29-23)31-21-8-9-22-20(15-21)10-11-28-22/h1-3,5-6,8-12,14-18,28H,4,7,13H2,(H,29,30,31)
|
||||
| InChIKey |
VTLQAHPWBDJOFR-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Epidermal growth factor receptor III | Target Info | [1587926] | ||
| Vascular endothelial growth factor receptor 1 | Target Info | [1587926] | |||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.